Estee Lauder, a prominent player in the prestige beauty market, recently announced its fiscal 2025 guidance, which left investors and analysts disappointed. The company’s organic net sales are expected to decline by 1% to potentially increase by 2%, a far cry from the anticipated 6% to 7% growth consensus. Similarly, the profit outlook is also
0 Comments
Starbucks, the once beloved coffee giant, has been struggling in recent times due to operational issues, mobile order complications, and changing consumer behaviors. With the upcoming appointment of Brian Niccol as the new CEO, the company faces a pivotal moment in its turnaround strategy. Operational Challenges The operational challenges faced by Starbucks have been a
0 Comments
One of the top stock picks favored by Wall Street analysts in July was project management software provider Monday.com (MNDY). The company impressed investors with its strong second-quarter results and raised full-year outlook, thanks to the high demand from large customers. This led TD Cowen analyst Derrick Wood to boost his firm’s price target for
0 Comments
Gilead Sciences recently exposed a counterfeit drug operation involving its HIV medications that had been tampered with and illegally resold before reaching unsuspecting patients. This illicit scheme, allegedly orchestrated from two New York City pharmacies, was reportedly masterminded by Peter Khaim, a twice-convicted medical fraudster. The court documents unveiled this month revealed that Khaim was
0 Comments